-+ 0.00%
-+ 0.00%
-+ 0.00%

VISTAGEN THERAPEUTICS, - PREPARING TO MEET WITH FDA THIS QUARTER FOR PROPOSED NEW PHASE 3 TRIAL

Reuters·09/22/2026 12:30:01

Please log in to view news